March 10, 2022

Direct Digital Holdings, Inc. (DRCT) Stock Sinking in Premarket. Here’s What Happened.

Leave a Comment / Featured, Morning News / Maria Masood

Direct Digital Holdings, Inc. (DRCT) conveys advanced advertising portfolios under one parent company. The company’s Sell-side portfolio Colossus SSP delivers the extensive general market reach and diverse media assets to its advertisers. The operating companies of the group include Huddled Masses and Orange142, which offer considerable ROI for middle-market promoters. The company’s solutions achieve 56,000 […]

Direct Digital Holdings, Inc. (DRCT) Stock Sinking in Premarket. Here’s What Happened. Read More »

Why is THORChain’s Rune Pumping?

Leave a Comment / Crypto News / Ammar Mukhtar

Protocol for inter-chain communication THORChain launched synthetic asset trading on its platform this morning, leading values of its native token RUNE to rise by up to 37% from Wednesday’s lows of $4.05 to Thursday’s high of $5.56. Synthetic assets, or blockchain-based representations of other assets, such as cryptocurrency, are backed by half the value of

Why is THORChain’s Rune Pumping? Read More »

DXF pre-market Climb – In for a Ride or False Optimism

Leave a Comment / Featured, Morning News / Wasim Omar

Market participants looking towards Dunxin Financial Holdings Limited (DXF) woke up to big movements this morning. This was because, later in the after-hours of yesterday’s trade, and early in today’s premarket, traders saw a growth swing that was nothing short of extraordinary. Total gain as of yet, since yesterday’s trade initiated, has been close to

DXF pre-market Climb – In for a Ride or False Optimism Read More »

Growth Potential for ANPC, Despite Persistent Downward Spiral?

Leave a Comment / Featured, Market News, Morning News / Wasim Omar

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) is one penny stock that has traders’ attention gripped after yesterday’s trade session. Pushing into the pre-market, traders saw a net rise of 14.8%, reaching a peak of $0.75 at a certain point. This comes amidst a general bearish movement persisting from a month ago, losing 26.5% in

Growth Potential for ANPC, Despite Persistent Downward Spiral? Read More »

Longeveron Inc. (LGVN) stock Surges Premarket a Day Before Earnings Report

Leave a Comment / Featured, Morning News / Gule Rukhsar

On March 10, Longeveron Inc. (LGVN) stock surged by 26.73% in the premarket, at the last check. The company is set to declare its Q4 and fiscal 2021 financial results on March 11, 2022, before the opening of the market. The company will be hosting the earnings conference call tomorrow at 8:20 am, EST during

Longeveron Inc. (LGVN) stock Surges Premarket a Day Before Earnings Report Read More »

ENGlobal Corp. (ENG) Stock Recoiled Premarket, Here’s why.

Leave a Comment / Featured, Market News / Maria Masood

ENGlobal Corp. (ENG) is a leader in providing whole platform solutions for renewable and conventional energy globally. The company runs via two business segments including Commercial and Government sectors. The Commercial sector offers its clients with engineering, fabrication, and integration of automatic control platforms as a comprehensive packaged solution. The Governmental sector provides its government

ENGlobal Corp. (ENG) Stock Recoiled Premarket, Here’s why. Read More »

CPNG Going in for the Kill – Tumultuous Trajectory amidst Robust Potential

Leave a Comment / Featured, Market News / Wasim Omar

Stock for Coupang, Inc. (CPNG) has been on a tumultuous roll today seeing a steady bullish climb of 10.5%. A sharp plummet of 7.3% then followed in the after-hours of trade. In fact, most of the last week had been sporadic for CPNG, both rising and dropping at substantial levels. The market continues to closely

CPNG Going in for the Kill – Tumultuous Trajectory amidst Robust Potential Read More »

Salarius Pharmaceuticals, Inc. (SLRX) Stock Rebounds Aftermarket, Here’s What’s Happening.

Leave a Comment / Featured, Morning News / Maria Masood

Salarius Pharmaceuticals, Inc. (SLRX) is a leading late-stage biotherapeutics firm engaged in developing cancer therapeutics for oncology patients. The lead pipeline candidate of the company is Seclidemstat in Phase 1/2 clinical-stage used for treating prostate, breast, ovary cancer, and tumors. The price of SLRX stock during the regular trading of March 9, 2022, was $0.37

Salarius Pharmaceuticals, Inc. (SLRX) Stock Rebounds Aftermarket, Here’s What’s Happening. Read More »

Couchbase Inc (BASE) stock plunged in the after-market. Here’s why

Leave a Comment / Featured, Morning News / Mustafa Bin Tariq

The stock of Couchbase Inc (BASE) closed the recent trading session at $18.56, gaining 6.3% from the previous day’s trading session. On the last check, the stock lost 13.25% to $16.1 in the after-market. On 9 March 2022, Couchbase Inc (BASE) released the fiscal performance for Q4 and FY2022. The company also presented the financial

Couchbase Inc (BASE) stock plunged in the after-market. Here’s why Read More »

2021 Financial Results: Fossil Group Inc. (FOSL) stock Slides After Hours on Poor Outlook

Leave a Comment / Featured, Morning News / Gule Rukhsar

On March 09, Fossil Group Inc. (FOSL) declared its financial results for the fourth quarter and fiscal 2021 after the market closed. Along with this, the company also provided an outlook for fiscal 2022 which disappointed the investors. Consequently, the stock plunged down in the after-hours on Wednesday. During the regular trading session, the stock

2021 Financial Results: Fossil Group Inc. (FOSL) stock Slides After Hours on Poor Outlook Read More »